SCHEMBL8305043

SCHEMBL8305043

OCCO/N=C\c1cccc(-c2ccccc2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UNG P13051 3/20 0.46
HDAC1 Q13547 1/20 0.42
HDAC2 Q92769 1/20 0.42
KCNH2 Q12809 1/20 0.41
TAAR1 Q96RJ0 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
ALDH1A1 P00352 1/20 0.38
RECQL P46063 1/20 0.38
PLAAT3 P53816 1/20 0.36
PLAAT5 Q96KN8 1/20 0.36
PLAAT2 Q9NWW9 1/20 0.36
PLAAT4 Q9UL19 1/20 0.36
TRIM24 O15164 1/20 0.36
TRIM33 Q9UPN9 1/20 0.36
NPC1 O15118 1/20 0.36
GAA P10253 1/20 0.36
RAB9A P51151 1/20 0.36
ATM Q13315 1/20 0.36
SRC P12931 2/20 0.36
PLA2G7 Q13093 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8305044 1.00 UNG (0.46) UNGHDAC1HDAC2KCNH2TAAR1
SCHEMBL8308913 0.85 HDAC2 (0.54) HDAC1HDAC2TAAR1SMN1; SMN2ALDH1A1
SCHEMBL8308910 0.85 HDAC2 (0.54) HDAC1HDAC2TAAR1SMN1; SMN2ALDH1A1
SCHEMBL8306342 0.85 TAAR1 (0.47) UNGHDAC1HDAC2TAAR1SMN1; SMN2
SCHEMBL8306343 0.85 TAAR1 (0.47) UNGHDAC1HDAC2TAAR1SMN1; SMN2
SCHEMBL8307808 0.82 TAAR1 (0.46) UNGHDAC1HDAC2TAAR1ALDH1A1
SCHEMBL8307807 0.82 TAAR1 (0.46) UNGHDAC1HDAC2TAAR1ALDH1A1
SCHEMBL8307151 0.76 ALDH1A1 (0.54) SMN1; SMN2ALDH1A1GAAMEN1LMNA
SCHEMBL8307153 0.76 ALDH1A1 (0.54) SMN1; SMN2ALDH1A1GAAMEN1LMNA
SCHEMBL8304980 0.75 TAAR1 (0.44) HDAC1HDAC2TAAR1SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
US-5780490-A A O-(2,4-OXA(OR THIA)ZOLIDINYL)PHENYLOXY(OR THIO OR AMINO) ALKYLOXIME; ALDOSE REDUCTASE INHIBITORS; ANTIDIABETIC AND -HYPOGLYCEMIC AGENTS; LIVER, SKIN AND UROGENITAL DISORDERS SANKYO COMPANY, LIMITED (JP) 1998-07-14 US disclosed
US-5703096-A ANTIDIABETIC AGENTS; ALDOSE REDUCTASE INHIBITOR SANKYO COMPANY, LIMITED (JP) 1997-12-30 US disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed